These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 7867755

  • 1. Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats.
    Adams CE, Hoffman AF, Hudson JL, Hoffer BJ, Boyson SJ.
    Exp Neurol; 1994 Dec; 130(2):261-8. PubMed ID: 7867755
    [Abstract] [Full Text] [Related]

  • 2. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Blunt S, Jenner P, Marsden CD.
    Neuroscience; 1991 Dec; 40(2):453-64. PubMed ID: 1902916
    [Abstract] [Full Text] [Related]

  • 3. Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts.
    Wang Y, Wang SD, Lin SZ, Liu JC.
    J Pharmacol Exp Ther; 1994 Aug; 270(2):814-21. PubMed ID: 7915321
    [Abstract] [Full Text] [Related]

  • 4. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
    [Abstract] [Full Text] [Related]

  • 5. Influence of environment on the efficacy of intrastriatal dopaminergic grafts.
    Döbrössy MD, Le Moal M, Montaron MF, Abrous N.
    Exp Neurol; 2000 Sep; 165(1):172-83. PubMed ID: 10964496
    [Abstract] [Full Text] [Related]

  • 6. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG, Dziewczapolski G, Menalled LB, García MC, Agid Y, Gershanik O, Raisman-Vozari R.
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
    Agnati LF, Leo G, Vergoni AV, Martínez E, Hockemeyer J, Lluis C, Franco R, Fuxe K, Ferré S.
    Brain Res Bull; 2004 Aug 30; 64(2):155-64. PubMed ID: 15342103
    [Abstract] [Full Text] [Related]

  • 8. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 30; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 9. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J.
    Exp Neurol; 2001 Jan 30; 167(1):148-57. PubMed ID: 11161602
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
    Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M.
    Brain Res; 2008 Jul 07; 1218():13-20. PubMed ID: 18513704
    [Abstract] [Full Text] [Related]

  • 12. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK, Granata R, Laboyrie PM, Quinn NP, Jenner P, Marsden CD.
    Mov Disord; 1996 Sep 07; 11(5):522-32. PubMed ID: 8866493
    [Abstract] [Full Text] [Related]

  • 13. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL, Brundin P, Cenci MA.
    Neurobiol Dis; 2009 Jul 07; 35(1):42-51. PubMed ID: 19361557
    [Abstract] [Full Text] [Related]

  • 14. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
    Bouchez G, Sensebé L, Vourc'h P, Garreau L, Bodard S, Rico A, Guilloteau D, Charbord P, Besnard JC, Chalon S.
    Neurochem Int; 2008 Jun 07; 52(7):1332-42. PubMed ID: 18372079
    [Abstract] [Full Text] [Related]

  • 15. Morphological and behavioral drawbacks of fetal dopaminergic grafts, prelabeled with Phaseolus vulgaris leucoagglutinin.
    Dolleman-Van der Weel MJ, Nijssen A, Steinbusch HW.
    Exp Neurol; 1993 Aug 07; 122(2):260-72. PubMed ID: 8405263
    [Abstract] [Full Text] [Related]

  • 16. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A.
    Brain; 2009 Feb 07; 132(Pt 2):319-35. PubMed ID: 19039008
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar 07; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 18. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
    Chang WY, Webster RA.
    Br J Pharmacol; 1997 May 07; 121(2):331-7. PubMed ID: 9154345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.